The Challenges of the Analytical Control Strategy for Seasonal Multivalent mRNA Vaccines

Time: 4:40 pm
day: Conference Day One


  • Discussing potency methods: constraints for the development of potency methods, in the specific case of (multivalent) mRNA vaccines
  • Exploring critical reagents: potential strategies for the definition and usage of cross-industry-regulators reference standards for mRNA vaccines
  • Uncovering commercial readiness: how to design control strategies for an efficient and seamless commercial release of mRNA vaccines